Site icon Dynamite News

SC issues notice to IRDA on exclusion of epilepsy from health insurance coverage

Supreme Court on Tuesday issued notice to the Insurance Regulatory and Development Authority of India. Read further on Dynamite News
Post Published By: Surender Singh
Published:
SC issues notice to IRDA on exclusion of epilepsy from health insurance coverage

New Delhi: The Supreme Court on Tuesday issued notice to the Insurance Regulatory and Development Authority of India (IRDA) in a Public Interest Litigation (PIL) challenging the permanent exclusion of epilepsy from health insurance coverage. reports Dynamite News correspondent.
The petition, filed under Article 32 of the Constitution, seeks relief for Persons with Epilepsy (PWE), arguing that the exclusion is discriminatory and violates fundamental rights under Articles 14 and 21.
We have nothing to lose…” Brother Akash warns Lalu over Tej Pratap-Anushka controversy
According to Dynamite News correspondent, a bench comprising Justice B.V. Nagarathna and Justice Satish Chandra Sharma issued the notice after hearing submissions that the IRDA’s Master Circular dated July 22, 2020, mandates a permanent exclusion of epilepsy from standard health insurance policies.
The petitioner contended that the exclusion unjustly deprives persons suffering from epilepsy of access to adequate healthcare and insurance benefits available to those with other medical conditions.
Padma Awards 2025 Live: 71 individuals honored with Padma Awards, Here’s full details
It was argued that the policy is unscientific, irrational, and based on outdated assumptions regarding the risks associated with epilepsy. “It is submitted that the decision to classify epilepsy as a disease under permanent exclusion is not only scientifically flawed but also unconstitutional,” the plea stated.
India clears indigenous AMCA Fighter Jet Program, here’s what makes it special
The petition emphasised that the denial of insurance coverage results in serious restrictions on the ability of PWEs to access necessary medical treatment.
Hong Kong set to become international mediation hub in significant global milestone
Highlighting advancements in epilepsy treatment, the petitioner pointed out that up to 70% of individuals living with epilepsy can attain complete seizure remission through timely and appropriate Anti-Seizure Medications (ASMs).
The blanket exclusion fails to acknowledge these medical developments and perpetuates stigma and discrimination, the petitioner argued.
Meerut: Police held a man forcefully kissing a woman in public; Says, ‘Please forgive me’
Further, the petition claimed that IRDA and health insurance providers make a flawed presumption that all health complications in PWEs stem from their epilepsy diagnosis, which is not always the case.
Stay tuned to Dynamite News for further updates.
Exit mobile version